Google on Tuesday announced that it is opening access to Bard, an artificial intelligence chatbot powered by a large language model (LLM). Bard is Google's answer to OpenAI's ChatGPT, which has exploded in popularity since going public late last year. 

"We’ve learned a lot so far by testing Bard, and the next critical step in improving it is to get feedback from more people," the company wrote in a blog post.

In the big tech firm race to dominate the AI space, Google has proven to be more cautious than the Microsoft-based OpenAI. While ChatGPT has become the current byword for AI, Google's has struggled to generate the same excitement. 

With the decision to make Bard public, Google is stepping off of the sidelines — though it isn't throwing caution to the wind either.  

"While LLMs are an exciting technology, they’re not without their faults," the company wrote. "For instance, because they learn from a wide range of information that reflects real-world biases and stereotypes, those sometimes show up in their outputs. And they can provide inaccurate, misleading or false information while presenting it confidently."

This is exactly what happened when Google unveiled the tool at a press conference. It gave the wrong answer to a question about a major scientific achievement, a mistake which kicked off an 8 percent plunge in Google parent Alphabet's stock price. 

Google added that the testing process is designed to avoid these pitfalls by figuring out where guardrails need to be built to make sure interactions are "helpful and on topic."

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More